Trial Profile
A multicenter, open-labeled, randomized, parallel-group study comparing fluticasone propionate nasal spray and oral fexofenadine hydrochroride [hydrochloride] as early seasonal treatment for Japanese cedar pollinosis
Status:
Not yet recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Fexofenadine (Primary) ; Fluticasone propionate (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Acronyms FOREST
- 19 Jan 2007 New trial record.